Cargando…
Primary PCI versus pharmacoinvasive strategy for ST elevation myocardial infarction
BACKGROUND: The rationale for pharmacoinvasive strategy is that many patients have a persistent reduction in flow in the infarct-related artery. The aim of the present study is to assess safety and efficacy of pharmacoinvasive strategy using streptokinase compared to primary PCI and ischemia driven...
Autores principales: | Helal, Ayman M., Shaheen, Sameh M., Elhammady, Walid A., Ahmed, Mohamed I., Abdel-Hakim, Ahmed S., Allam, Lamyaa E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205251/ https://www.ncbi.nlm.nih.gov/pubmed/30402534 http://dx.doi.org/10.1016/j.ijcha.2018.10.006 |
Ejemplares similares
-
Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction
por: Sethi, Rishi, et al.
Publicado: (2023) -
Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment
por: de Andrade Falcão, Felipe José, et al.
Publicado: (2013) -
Ticagrelor or clopidogrel dual antiplatelet therapy following a pharmacoinvasive strategy in ST‐segment elevation myocardial infarction
por: Welsh, Robert C., et al.
Publicado: (2021) -
STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
por: ElGuindy, Ahmed M.
Publicado: (2014) -
Inferior ST-elevation myocardial infarction managed with a pharmacoinvasive strategy and conservative management of delayed atrioventricular block: classical case report
por: John, Thadathilankal-Jess, et al.
Publicado: (2020)